| |
|
|
| |
|
|
| |
HUM-MOLGEN
-> Events
-> Courses and Workshops |
|
|
| |
| |
| |
January 15, 2014 |
|
|
| |
|
|
| |
|
|
|
Center for Professional Innovation & Education, Inc., Berlin, Germany
May 5 & 6, 2014
This two-day course is designed to provide individuals with a detailed understanding of the important regulatory guidelines involved in the development of a new product plan within the EU. The program will also cover effective strategies for correctly applying the current regulations to ensure that rejections are avoided. The course will provide the attendee with a thorough knowledge of the following topics: - How to develop a regulatory strategy
- How to deal with pricing and reimbursement issues in your development
- How to validate your regulatory strategy (scientific advice) and how to choose between centralized and national scientific advice
- When does your product qualify as an orphan medicinal product and what are the advantages if it does?
- How to deal with pediatric development plans
- What has to be considered for Advanced Therapy Medicinal Product and oncology medicinal products
|
|
|
|
|
|
|
|
Organized by:
|
|
Center for Professional Innovation & Education |
|
|
Invited Speakers:
|
|
Contact info@cfpie.com for a list of course instructors
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
n/a
|
|
|
|
|
|
|
|
Registration:
|
|
http://www.cfpie.com/showitem.aspx?productid=132&utm_source=Hum-Molgen&utm_medium=Course%20Listing&utm_campaign=Web%20Listing%3A%20Hum-Molgen
|
|
|
E-mail:
|
|
info@cfpie.com
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp,
Frank S.
Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved.
Liability, Copyright and Imprint. |
|